Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.
D000328:Adult; D000368:Aged; D001808:Blood Vessels / Q000032:analysis*; D010450:Endopeptidases / Q000302:isolation & purification; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007074:Immunoglobulin G; D007526:Isoelectric Point; D007610:Kallikreins / Q000037:antagonists & inhibitors; D007866:Leg; D008875:Middle Aged; D008970:Molecular Weight; D010455:Peptides / Q000302:isolation & purification*; D010477:Perfusion; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors / Q000302:isolation & purification*; D015849:Plasminogen Inactivators; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
D007074:Immunoglobulin G; D010455:Peptides; D015849:Plasminogen Inactivators; D010450:Endopeptidases; D007610:Kallikreins; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator